[go: up one dir, main page]

AU2003268023A1 - Protein modification and maintenance molecules - Google Patents

Protein modification and maintenance molecules

Info

Publication number
AU2003268023A1
AU2003268023A1 AU2003268023A AU2003268023A AU2003268023A1 AU 2003268023 A1 AU2003268023 A1 AU 2003268023A1 AU 2003268023 A AU2003268023 A AU 2003268023A AU 2003268023 A AU2003268023 A AU 2003268023A AU 2003268023 A1 AU2003268023 A1 AU 2003268023A1
Authority
AU
Australia
Prior art keywords
protein modification
maintenance molecules
molecules
maintenance
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003268023A
Other languages
English (en)
Other versions
AU2003268023A8 (en
Inventor
Chandra S. Arvizu
Mariah R. Baughn
Shanya D. Becha
Julie J. Blake
Narinder K. Chawla
Vicki S. Elliott
Brooke M. Emerling
Ameena R. Gandhi
Kimberly J. Gietzen
Jennifer A. Griffin
April J. A. Hafalia
Craig H. Ison
Alan A. Jackson
Xin Jiang
Pei Jin
Amy E. Kable
Deborah A. Kallick
Liam Kearney
Reena Khare
Preeti G. Lal
Ernestine A. Lee
Soo Yeun Lee
Dyung Aina M. Lu
Yan Lu
Joseph P. Marquis
Danniel B. Nguyen
Jayalaxmi Ramkumar
Thomas W. Richardson
William W. Sprague
Anita Swarnakar
Catherine M. Tribouley
Amy D. Wilson
Junming Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Publication of AU2003268023A8 publication Critical patent/AU2003268023A8/xx
Publication of AU2003268023A1 publication Critical patent/AU2003268023A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2003268023A 2002-07-23 2003-07-23 Protein modification and maintenance molecules Abandoned AU2003268023A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US39814302P 2002-07-23 2002-07-23
US60/398,143 2002-07-23
US40245802P 2002-08-09 2002-08-09
US60/402,458 2002-08-09
US40328902P 2002-08-12 2002-08-12
US60/403,289 2002-08-12
US40647202P 2002-08-27 2002-08-27
US60/406,472 2002-08-27
US40935402P 2002-09-06 2002-09-06
US60/409,354 2002-09-06
PCT/US2003/023249 WO2004009797A2 (fr) 2002-07-23 2003-07-23 Molecules de modification et d'entretien de proteines

Publications (2)

Publication Number Publication Date
AU2003268023A8 AU2003268023A8 (en) 2004-02-09
AU2003268023A1 true AU2003268023A1 (en) 2004-02-09

Family

ID=30773751

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003268023A Abandoned AU2003268023A1 (en) 2002-07-23 2003-07-23 Protein modification and maintenance molecules

Country Status (2)

Country Link
AU (1) AU2003268023A1 (fr)
WO (1) WO2004009797A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006090389A2 (fr) 2005-02-24 2006-08-31 Compugen Ltd. Nouveaux marqueurs diagnostiques, en particulier pour l'imagerie in vivo, et dosage et procedes d'utilisation associes
US7943328B1 (en) 2006-03-03 2011-05-17 Prometheus Laboratories Inc. Method and system for assisting in diagnosing irritable bowel syndrome
US20080085524A1 (en) 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
JP2010507387A (ja) 2006-10-25 2010-03-11 クアーク・ファーマスーティカルス、インコーポレイテッド 新規のｓｉＲＮＡおよびその使用方法
JP5646997B2 (ja) 2007-10-03 2014-12-24 クォーク ファーマシューティカルズ インコーポレーティッドＱｕａｒｋ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 新規ｓｉＲＮＡ構造
SG188497A1 (en) 2010-09-22 2013-05-31 Alios Biopharma Inc Substituted nucleotide analogs
HK1203075A1 (en) 2011-12-22 2015-10-16 艾丽奥斯生物制药有限公司 Substituted phosphorothioate nucleotide analogs
EP2828277A1 (fr) 2012-03-21 2015-01-28 Vertex Pharmaceuticals Incorporated Formes solides d'un promédicament nucléotidique thiophosphoramidate
HK1203356A1 (en) 2012-03-22 2015-10-30 艾丽奥斯生物制药有限公司 Pharmaceutical combinations comprising a thionucleotide analog

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618966D0 (en) * 1996-09-11 1996-10-23 Smithkline Beecham Plc Novel compounds
US6225103B1 (en) * 1996-11-20 2001-05-01 Oklahoma Medical Research Foundation Cloning and characterization of napsin
EP1030911A1 (fr) * 1998-07-16 2000-08-30 Incyte Pharmaceuticals, Inc. Proteases aspartiques humaines

Also Published As

Publication number Publication date
WO2004009797A3 (fr) 2004-12-02
WO2004009797A2 (fr) 2004-01-29
AU2003268023A8 (en) 2004-02-09

Similar Documents

Publication Publication Date Title
AU2002227280A1 (en) Protein modification and maintenance molecules
AU2002950303A0 (en) Improvements in assembly and disassembly
AU2002258388A1 (en) Narc8 programmed cell-death-associated molecules and uses thereof
AU2002318356A1 (en) Protein modification and maintenance molecules
AU2001270271A1 (en) Protein modification and maintenance molecules
AU2003300815A1 (en) Protein modification and maintenance molecules
AU2003268023A1 (en) Protein modification and maintenance molecules
AU2003205353A1 (en) Protein modification and maintenance molecules
EP1572168A3 (fr) Molecules anti-infarcissement
AU2002253883A1 (en) Protein modification and maintenance molecules
AU2003231981A1 (en) Protein modification and maintenance molecules
AUPS187002A0 (en) Condition-specific molecules and uses therefor
AU2003239871A1 (en) Protein modification and maintenance molecules
AU2002343515A1 (en) Protein modification and maintenance molecules
AU2002953223A0 (en) Novel therapeutic molecules and uses thereof
AU2003235096A1 (en) Novel protein and dna thereof
AU2002336529A1 (en) Protein modification and maintenance molecules
AU2002258724A1 (en) Protein modification and maintenance molecules
AU2003279829A1 (en) Protein modification and maintenance molecules
AU2003236374A1 (en) Atopic dermatitis-inducing proteins
AU2003298589A1 (en) Protein modification and maintenance molecules
AU2003280992A1 (en) Novel proteins and use thereof
AU2003219732A1 (en) Oligomeric molecules and uses thereof
AU2003292721A1 (en) Novel protein and its gene
AU2003262080A1 (en) Novel protein and dna thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase